In late 2020, Hilco Streambank was retained to market for sale key patents for devices and techniques related to surgical treatments for mitral regurgitation and atrial fibrillation. This patent portfolio was previously brought to market by Hilco Streambank in 2019 as part of the receivership of LC Therapeutics, Inc., and had been sold to one of the co-founders of the company that developed the patents.
Hilco Streambank ran a comprehensive marketing campaign for the patent portfolio and solicited best and final offers from prospective purchasers. We worked closely with the seller to negotiate a sale of the patents and close a transaction with the buyer in 2021. Deal terms have not been disclosed.